NDC 71894-200 – Itvisma

Onasemnogene Abeparvovec 40000000000000 [arb'U]/mL · Injection, Suspension · Intrathecal

Human Prescription Drug

Product NDC71894-200

Product details

Brand name
Itvisma
Generic name
onasemnogene abeparvovec-brve
Labeler
Novartis Innovative Technologies Inc.
Dosage form
Injection, Suspension
Route
Intrathecal
Marketing category
BLA · BLA125856
Marketed since
November 24, 2025
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Itvisma →

Package NDC codes (1)

Package NDCDescriptionSince
71894-200-021 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01)Nov 24, 2025